“We are facing an exciting era of fast-paced drug development in acute myeloid leukaemia” writes Gianfranco Bittar and colleagues at Baylor College of Medicine, Houston, TX, USA, in a review published in touchREVIEWS in Oncology & Haematology. In 2020, there were an estimated 21,450 new patients with acute myeloid leukaemia (AML) and 11,180 AML-related deaths […]
Advertisement
touchHAEMATOLOGY
Register Now!
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
Save your progress for video
Keep track of your CME credits
Add personalised learning notes
Receive updates from course leaders and faculty
Be the first to hear about new and exciting interactive learning opportunities
Register Register
Login
Login
Sign Up FREE
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register now for FREE Access
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.